Trasylol Lawsuit

There are estimates that at least 10,000 patients may unnecessarily have suffered kidney damage due to use of aprotinin during heart surgery. Many patients may have been injected with Trasylol to reduce blood loss during coronary artery bypass (CABG) surgery. We are currently representing patients and families throughout the United States and filing a Trasylol lawsuit against the drug Trasylol manufacturer Bayer.

The Food and Drug Administration approved Aprotinin in 1993, a drug marketed by Bayer as Trasylol. Sales of Trasylol over the past several years have escalated to more than $600 million.

Trasylol Attorneys

Patients undergoing heart surgery are largely unaware if Trasylol was used during their heart surgery. The decision to use aprotinin (Trasylol) was made by a patient's treating doctor.

We realize that most patients have had successful heart surgeries and are concerned that nothing negative happens to their doctors. We are here to make sure that if you have suffered Trasylol kidney damage, stroke or heart failure we will work to hold the responsible drug company accountable.

Trasylol Linked to Kidney Failure, Stroke and Heart Attacks

A recent study, published by the New England Journal of Medicine (NEJM) (2006) reported a connection between Trasylol and increased risk of renal (kidney) failure, myocardial infarction, heart failure or stroke in patients who have had heart surgery.

What is Aprotinin Injection?

Aprotinin (Trasylol) affects the way in which blood clots. Trasylol is injected into patients who are undergoing open heart surgery. Excessive bleeding, during and after heart surgery, is a serious complication. Such bleeding exposes patients to multiple risks. Trasylol is primarily used during repeat coronary artery bypass surgery to reduce the amount of bleeding. The amount of blood transfusion required is reduced by using clotting medications including Trasylol.

Alternative Drugs Available - Safer and Less Expensive

The NEJM study concluded that 2 other generic drugs are available that are safer and less expensive than Trasylol.

1. The generic Amicar cost per dose s $11
2. The generic Cyklokapron cost per dose is $44
3. Trasylol cost per dose is $1300.

Neither of the generic drugs was associated with increased risk of kidney failure, heart attack or stroke.

Trasylol Renal Failure and Heart Failure Warnings

The federal Food and Drug Administrations (FDA) Cardiovascular and Renal Drug Advisory Committee met on September 21, 2006 to review recent data regarding the safety of aprotinin. On September 29, 2006, the FDA issued a public health advisory stating that it had learned Bayer failed to disclose a study that Bayer had conducted involving 67,000 patients undergoing heart surgery. Preliminary analysis of the Bayer study suggested that Trasylol use was linked with risk for congestive heart failure, renal failure, stoke and death. Bayer did not disclose the study during the September 21, 2006 Advisory Committee meeting.

If you or a loved one has had open heart surgery and then experienced Trasylol kidney damage, heart failure or stroke, you may be able entitled to money damages. Trasylol attorneys can help evaluate your claim.